Aminophylline in the hospital treatment of children with acute asthmaBMJ 1994; 308 doi: https://doi.org/10.1136/bmj.308.6941.1384 (Published 28 May 1994) Cite this as: BMJ 1994;308:1384
- S A McKenzie
In 1971 Pierson and colleagues showed that in children with acute asthma, intravenous aminophylline provided additional benefit when added to a regimen of hydrocortisone and sympathomimetic drugs.1 As these drugs are pharmacologically different and each causes bronchodilatation it seemed reasonable that together their effect would be additive. For children with poor pulmonary function (peak flow <25% expected) or with hypercapnoea (arterial carbon dioxide pressure >5 kPa) this combination seemed to work2: less severely ill children recovered when given oral prednisolone and nebulisedsalbutamol and did not need inpatient care.
For nearly 20 years children with acute asthma have been managed along these lines. Recent practice, however, has seen the intravenous treatment of children with severe asthma replaced by the regimen now used to treat …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial